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Graphical Abstract Highlights
• Extensive lncRNA translation and microprotein
production during human pancreas development
• A small-scale loss-of-function screen shows most
translated lncRNAs are dispensable
• LINC00261 is highly translated and regulates
endocrine cell differentiation
• Deleting LINC00261’s evolutionary young
microproteins reveals no essential roles
Abstract
Long noncoding RNAs (lncRNAs) are a heterogenous group of RNAs, which can encode small proteins. The
extent to which developmentally regulated lncRNAs are translated and whether the produced microproteins
are relevant for human development is unknown. Here, we show that many lncRNAs in direct vicinity of
lineage-determining transcription factors (TFs) are dynamically regulated, predominantly cytosolic, and highly
translated during pancreas development. We genetically ablated ten such lncRNAs, most of them translated,
and found that nine are dispensable for endocrine cell differentiation. However, deletion of LINC00261
diminishes generation of insulin+ endocrine cells, in a manner independent of the nearby TF FOXA2.
Systematic deletion of each of LINC00261’s seven poorly conserved microproteins shows that the RNA, rather
than the microproteins, is required for endocrine development. Our work highlights extensive translation of
lncRNAs into recently evolved microproteins during human pancreas development and provides a blueprint for
dissection of their coding and noncoding roles.
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INTRODUCTION
Defects in pancreatic endocrine cell development confer
increased diabetes risk later in life (Bakhti et al., 2019).
Therefore, a detailed understanding of the factors that
orchestrate endocrine cell differentiation is highly relevant
to human disease. Many of the molecular mechanisms that
underlie the formation of pancreatic endocrine cells have
been defined (Schiesser & Wells, 2014; Romer & Sussel,
2015), but a thorough functional assessment of the
noncoding transcriptome, and in particular that of long
noncoding RNAs (lncRNAs), is currently lacking.
Most lncRNAs with to date demonstrated roles in the
regulation of fundamental developmental processes are
active in the cell’s nucleus (Klattenhoff et al., 2013; Lin
et al., 2014; Jiang et al., 2015; Kurian et al., 2015; Ramos
et al., 2015; Daneshvar et al., 2016; Luo et al., 2016).
However, a large proportion of lncRNAs is predominantly
cytosolic (van Heesch et al., 2014; Cabili et al., 2015), and
the functional relevance of these lncRNAs has remained
unexplored in the context of human development. It
is now widely accepted that many cytosolic lncRNAs
possess short, "non-canonical" open reading frames
(sORFs) that are actively translated (Bazzini et al., 2014;
Ruiz-Orera et al., 2014; Makarewich & Olson, 2017).
Although most of these non-canonical ORFs produce
microproteins that are poorly conserved across species,
recent studies have systematically assessed their biological
activity, revealing roles across cellular organelles and, for a
subset of microproteins, essential functions for cell survival
(van Heesch et al., 2019; Chen et al., 2020; Prensner et al.,
2020). This previously unrecognized coding capacity of
supposedly noncoding RNAs has called into question the
noncoding classification of lncRNAs, emphasizing the need
for careful dissection of any gene’s coding and noncoding
functions.
LncRNAs, whether translated or fully noncoding, are not
randomly distributed in the genome but frequently located
close to, and coregulated with, canonical protein-coding
genes in cis (Luo et al., 2016; Neumann et al., 2018;
van Heesch et al., 2019). For example, the lncRNAs
DIGIT (also known as GSC-DT ) and Gata6as (also
known as lncGata6 or GATA6-AS1) have been reported
to enhance expression of the divergently expressed
endoderm regulators Goosecoid (GSC) and Gata6,
respectively (Daneshvar et al., 2016 ; Luo et al., 2016;
Neumann et al., 2018). Similarly, LINC00261 (also
known as DEANR1) and its neighboring transcription factor
(TF) FOXA2 are both induced in endoderm formation,
during which LINC00261 has been demonstrated to
positively regulate FOXA2 expression (Jiang et al., 2015).
However, whether such cis-acting lncRNAs are translated
and may exert cytosolic functions through trans-acting,
microprotein-dependent mechanisms relevant for endoderm
and pancreas development is not known.
In this study, we newly identify actively translated lncRNAs
and analyze their role in human pancreas development.
We accomplished this by classifying lncRNAs based on
their dynamic regulation, subcellular localization, and active
translation during the stepwise differentiation of human
embryonic stem cells (hESCs) toward the pancreatic
fate. We used this classification to prioritize select
dynamically regulated and highly translated lncRNAs for
deletion in hESCs, followed by extensive phenotypic
characterization across multiple intermediate stages of
pancreas development. This small-scale loss-of-function
screen reveals that nine out of the ten selected lncRNAs are
not essential for pancreatic development and, despite their
vicinity to lineage-determining TFs, none of these lncRNAs
regulate the expression of these TFs in cis.
The deletion of one lncRNA, LINC00261, does impair
human endocrine cell development and leads to a significant
reduction in the number of insulin-producing cells. Contrary
to previous studies of LINC00261 knockdown hESCs (Jiang
et al., 2015), deletion of LINC00261 has no effect on
the expression of nearby TF FOXA2 or other proximal
genes, suggesting control of endocrine cell formation
through a trans- rather than cis-regulatory mechanism.
LINC00261 is one of the most highly translated lncRNAs
based on ribosome profiling (Ribo-seq) and produces
multiple microproteins with distinct subcellular localizations.
To systematically assess LINC00261’s coding and
noncoding functions, we separately introduced frame shift
mutations into each of seven identified LINC00261 sORFs.
However, rigorous phenotypic characterization revealed
no apparent consequences of loss of each of the seven
LINC00261-sORF-encoded microproteins on endocrine cell
development. Our comprehensive assessment of functional
lncRNA translation identifies a microprotein-independent
trans-regulatory role for LINC00261 in endocrine cell
differentiation and provides a blueprint for the proper
dissection of a gene’s coding and noncoding roles in a
human disease-relevant system.
RESULTS
LncRNAs and nearby lineage-determining transcription
factors exhibit dynamic coregulation during pancreas
development
To identify lncRNAs involved in the regulation of pancreas
development, we profiled RNA expression at five defined
stages of hESC differentiation toward the pancreatic
lineage: hESCs (ES), definitive endoderm (DE), primitive
gut tube (GT), early pancreatic progenitor (PP1), and
late pancreatic progenitor (PP2) (Figure 1A). While some
lncRNAs were constitutively expressed (n = 592; 25.3%),
the majority showed dynamic expression patterns, being
either strongly enriched in (n = 874; 37.4%), or specific to
(n = 871; 37.3%) a single developmental intermediate of
pancreatic lineage progression (Figure 1B and Table S1A).
The expression of many of these dynamically regulated
lncRNAs correlated with that of proximal coding genes
(Figure S1A-D and Table S1B,C), further exemplified by a
subset of lncRNAs that was specifically coregulated with the
key endodermal and pancreatic TFs GATA6, FOXA2, PDX1,
and SOX9 (Figure 1C,D). The tight expression coregulation
of these lncRNA-TF pairs is likely explained by a shared
chromatin environment (Figure S1E-H), which raises the
possibility that like the TFs, the function of the lncRNAs is
also required for endoderm and pancreas development.
Many pancreatic progenitor-expressed lncRNAs are
cytoplasmically enriched and translated
Although most functional roles described for lncRNAs
to date have been predominantly nuclear (Marchese
et al., 2017), multiple recent studies have shown that
many lncRNAs are cytosolic and actively translated
into sometimes biologically active microproteins
(Makarewich & Olson, 2017). To further characterize
the above-identified dynamically regulated lncRNAs, we
analyzed their subcellular localization and translation
potential
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Figure 1. LncRNA expression and regulation during pancreatic differentiation.
(A) Stages of directed differentiation from human embryonic stem cell (hESCs) to hormone-producing endocrine cells. The color scheme
for each stage is used across all figures. (B) K-means clustering of all lncRNAs expressed (RPKM ≥ 1) during pancreatic differentiation
based on their expression z-score (mean of n = 2 independent differentiations per stage; from CyT49 hESCs). Ten clusters were required
(k = 10). (C,D) Left: Scatterplots comparing the expression of early (C) and late (D) expressed endodermal transcription factors (TFs) with
the expression of their neighboring lncRNAs across 38 tissues. The dot color indicates the germ layer of origin of these tissues. Pearson
correlation coefficients and p-values (t-test) are displayed. Right: Distribution of the Pearson correlation coefficients for each TF with all
Ensembl 87 genes across the same 38 tissues. Dashed lines denote the correlation for the neighboring lncRNA, which for all lncRNAs
shown is higher than expected by chance. See also Figure S1 and Table S1.
using fractionation RNA-seq and Ribo-seq (Figure 2A).
Of all lncRNAs expressed in pancreatic progenitor cells
(PP2 cells), we classified 21% (n = 347) as localized to
the nucleus, whereas a larger number (n = 563; 34%)
primarily resided in the cytosol (Figure S2A and Table
S2A). This subcellular distribution of pancreatic lncRNAs
is in agreement with previous lncRNA localization studies
by us and others (Clark et al., 2012; van Heesch et al.,
2014; Cabili et al., 2015; Sun et al., 2015). LncRNAs
enriched in the cytosol were expressed at higher levels
than nucleus-localized lncRNAs, with expression levels
similar to canonical protein-coding mRNAs (Figure S2B).
Intriguingly, almost half of all cytosol-enriched lncRNAs (278
out of 563; 49.4%) displayed dynamic expression regulation
during the differentiation of hESCs to pancreatic progenitors,
suggesting that many lncRNAs with putative developmental
functions do not act in the nucleus, but instead in the cytosol
where they may be translated.
To investigate the translation potential of these cytosolic
lncRNAs, we used Ribo-seq, obtaining exceptionally
deep and high quality translatome coverage across six
replicate differentiations (Figure S2C and Table S2B).
As nearly 90% of the sequenced ribosomal footprints
exhibited clear 3-nucleotide codon movement characteristic
of active translation (Figure S2D-F), these data have
strong predictive value for the computational detection of
non-canonical ORFs in lncRNAs (Table S2C). Requiring
stringent reproducibility criteria (the exact ORF needed to
be detected by RiboTaper (Calviello et al., 2016) in at
least four out of the six replicates), we identified a total of
625 new sORFs in lncRNAs with a median length of 47
amino acids (aa) (Table S2D). The majority of detected
sORFs (76%; n = 477/625) is currently not present in
the sORFs.org database (Olexiouk et al., 2016) and thus
completely novel. The translated sORFs are located within
285 cytosolically localized lncRNAs (25.3% of all expressed
lncRNAs) (Figure S2B), which are expressed at higher
levels than untranslated lncRNAs (Figure S2G) and exhibit
translational efficiencies similar to mRNAs (Figure S2H and
Table S2E).
Of note, only few of the newly identified sORFs are
highly conserved across species, as judged by their low
PhyloCSF scores (Lin et al., 2011) (Table S2D). However,
the relevance of our ORF detection approach and the
importance of lowly conserved ORFs for human biology
have recently been demonstrated by several independent
studies, focusing on either cardiac biology (van Heesch
et al., 2019) or human cancer cell survival (Chen et al.,
2020; Prensner et al., 2020).To our knowledge, our data
constitute the first comprehensive set of non-canonical
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Figure 2. Cytosolic lncRNAs contain translated small open reading frames.
(A) Overview of experimental strategy for subcellular fractionation and Ribo-seq-based identification of translated small open reading
frames (sORFs) from lncRNAs expressed in PP2 cells. Replicates from six independent differentiations to the PP2 stage each for total
(polyA) RNA-seq and Ribo-seq experiments, and two biological replicates for the subcellular fractionation were analyzed. The histogram
on the far right depicts the size distribution of the sORF-encoded small peptides as number of amino acids (aa). The pie chart summarizes
the percentages of constitutively and dynamically expressed sORF-encoding lncRNAs during pancreatic differentiation of CyT49 hESCs.
(B-E) Left: Bar graphs showing nuclear and cytosolic expression (in RPKM) of lncRNAs RP11-834C11.4 (B), LINC00261 (C), MIR7-3HG
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(D), and LHFPL3-AS2 (E). Data are shown as mean ± S.D. (n = 2 biological replicates). Right: Subcellular fractionation RNA-seq,
Ribo-seq, and P-site tracks (ribosomal P-sites inferred from ribosome footprints on ribosome-protected RNA) for loci of the depicted
lncRNAs. Identified highest stringency sORFs (ORF in 6/6 replicates) are shown in red. For LINC00261, visually identified sORFs 1
and 2 are also shown. Heatmaps in the top right visualize the relative expression of the shown lncRNAs during pancreatic differentiation
(means of two biological replicates per stage), on a minimum (white)/maximum (dark blue) scale. (F) In vivo translation reporter assays
testing whether sORFs computationally defined in (A) give rise to translation products in HEK293T cells when fused in-frame to a GFP
reporter. Left: Schematic of the constructs (gray: PGK promoter, black: lncRNA sequence 5’ to sORF to be tested, red: sORF, green:
GFP ORF). Right: Representative DIC and GFP images of HEK293T cells transiently transfected with the indicated reporter constructs.
Scale bars = 50 µm. See also Figure S2 and Table S2.
human ORFs generated from a non-transformed human cell
model of development, providing a valuable resource for
future functional studies.
Translated pancreatic lncRNAs produce microproteins
with distinct subcellular localizations
Having established that many stage-specific pancreatic
lncRNAs are actively translated, we next sought to validate
their translation potential through independent experimental
approaches, and to demonstrate production of the predicted
microproteins at the protein level. To this end, we
first performed coupled in vitro transcription:translation
assays on endogenous and complete transcript isoforms
of four of the most highly translated lncRNAs (LINC00261,
RP11-834C11.4, LHFPL3-AS2, and MIR7-3HG; Figure
S2I; expression and ORF information in Figure 2B-E).
Second, we generated a series of in vivo translation
reporter constructs to assess the subcellular localization of
microproteins translated from each of ten sORFs derived
from the same four lncRNAs. Transient expression of
individual constructs carrying in-frame GFP fusions in
HEK293T cells produced GFP signal for all ten assayed
microproteins, which was abolished upon introduction of
a frameshift within the sORF or a stop codon following
the sORF sequence (Figure 2F and Figure S2J-L).
To rule out a possible localization bias induced by the
GFP fusion, we also expressed a FLAG-tag fusion
peptide (RP11-834C11.4 sORF-1xFLAG), which revealed
a cytoplasmic localization identical to the one observed for
the GFP construct (Figure S2J). While most sORF-GFP
fusion products were ubiquitously distributed throughout
transfected cells, LINC00261 sORF4-GFP specifically
localized to mitochondria (Figure S2K), and LINC00261
sORF7-GFP exhibited a perinuclear accumulation pattern
reminiscent of aggresomes (Figure S2L). Taken together,
our results validate the translation potential of sORFs
encoded by pancreatic progenitor-expressed lncRNAs and
show that these translation events result in robust production
of microproteins with different subcellular localizations.
Systematic knockout of translated lncRNAs during
pancreas development
To identify potential functional roles of translated
lncRNAs and the microproteins they produce in
pancreas development, we selected ten candidates for
CRISPR/Cas9-based genome editing in hESCs through
excision of the lncRNA promoter or entire lncRNA locus
(Figure 3A,B). These ten lncRNAs were prioritized based
on (i) high expression and endodermal tissue-specificity,
(ii) dynamic regulation during pancreas development, (iii)
abundant translation of sORFs, and (iv) proximity to TFs
with known roles in endoderm and pancreas development.
For seven of the selected lncRNAs, translation was highly
abundant and reproducibly detected across Ribo-seq
replicates: LINC00617 (also known as TUNAR; (Lin
et al., 2014)), GATA6-AS1 (also known as GATA6-AS;
(Neumann et al., 2018)), LINC00261, RP11-834C11.4,
SOX9-AS1, MIR7-3HG, and LHFPL3-AS2. Although for
two additional lncRNAs the translation potential could not
be determined, they were nonetheless included because of
a previously reported requirement for definitive endoderm
formation (DIGIT, also known as GSC-DT ) (Daneshvar
et al., 2016) and genomic localization adjacent to the
definitive endoderm TF LHX1 (RP11-445F12.1, also
known as LHX1-DT ). Lastly, LINC00479 was chosen as
a non-translated control with expression dynamics and a
subcellular localization similar to LINC00261. Of note, for
each of the ten selected lncRNAs, we generated at least two
independent hESC knockout (KO) clones and used different
combinations of single guide RNAs where possible (Table
S3A).
We next differentiated each of the lncRNA KO hESC
lines stepwise toward the pancreatic endocrine cell stage,
conducting up to 16 replicate differentiations per clone.
Because LINC00617, RP11-445F12.1, DIGIT, GATA6-AS1,
LINC00479, and LINC00261 were first expressed at, or
before, the definitive endoderm stage (Figure 3A), we
determined whether KO hESCs for these lncRNAs exhibited
defects in definitive endoderm formation. Despite efficient
lncRNA depletion (Figure S3A,B), neither quantification of
definitive endoderm marker gene expression by qRT-PCR,
nor immunofluorescence staining or flow cytometric
analysis of the definitive endoderm marker SOX17 showed
differences indicative of impaired endoderm formation in
lncRNA KO lines (Figure 3C-E). Importantly, expression
of TFs located in the direct vicinity of these lncRNAs,
including GSC (DIGIT ), LHX1 (RP11-445F12.1), GATA6
(GATA6-AS1), and FOXA2 (LINC00261), was unaffected
by the lncRNA KO (Figure 3F, Figure S3C, Table S3B-D),
arguing against cis-regulation by these lncRNAs. These
findings are in contrast to prior reports that have shown
a requirement for LINC00261 and DIGIT in definitive
endoderm formation and the regulation of neighboring
TFs FOXA2 and GSC, respectively (Jiang et al., 2015;
Daneshvar et al., 2016; Amaral et al., 2018; Swarr et al.,
2019).
Next, we further differentiated control and KO lines
for eight out of ten lncRNAs toward the endocrine cell
stage, excluding DIGIT and RP11-445F12.1 because they
are not expressed after the definitive endoderm stage
(Figure 3A). In KO hESC lines of seven out of these eight
lncRNAs, we observed no effect on pancreatic progenitor
cell formation or gene expression, with the exception of a few
dysregulated genes in LHFPL3-AS2 and RP11-834C11.4
KO cells (Figure S3C and Table S3E-K). Furthermore,
deletion of neither of the seven lncRNAs impaired endocrine
cell formation, as determined by quantification of insulin+
cells and insulin mRNA levels (Figure 3G-I). Similar to
the RNA expression results obtained at the definitive
endoderm stage, deletion of none of the lncRNAs close
to pancreatic TFs (e.g. GATA6-AS1 and SOX9-AS1) altered
the expression of these TFs, once more arguing against
cis-regulation of these TFs by the neighboring lncRNA
(Figure S3C).
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Figure 3. A small-scale CRISPR loss-of-function screen for dynamically expressed and translated lncRNAs during pancreatic
differentiation.
(A) qRT-PCR analysis of candidate lncRNAs during pancreatic differentiation of H1 hESCs relative to the ES stage. Data are shown as
mean ± S.E.M. (mean of n = 2-6 independent differentiations per stage; from H1 hESCs). (B) CRISPR-based lncRNA knockout (KO)
strategy in H1 hESCs and subsequent phenotypic characterization. (C) Immunofluorescence staining for OCT4 and SOX17 in DE from
control (ctrl) and KO cells for the indicated lncRNAs (representative images, n ≥ 3 independent differentiations; at least two KO clones
were analyzed). (D) qRT-PCR analysis of DE lineage markers in DE from control and lncRNA KO (-/-) cells. TF genes in cis to the lncRNA
locus are highlighted in red. Data are shown as mean ± S.E.M. (n = 3-16 replicates from independent differentiations and different KO
clones). NS, p-value > 0.05; t-test. (E) Flow cytometry analysis at DE stage for SOX17 in control and KO (-/-) cells for indicated lncRNAs.
The line demarks isotype control. Percentage of cells expressing SOX17 is indicated (representative experiment, n ≥ 3 independent
differentiations from at least two KO clones). (F) Immunofluorescence staining for FOXA2 or GATA6 in DE from control and LINC00261,
GATA6-AS1, and DIGIT KO cells. (G) Immunofluorescence staining for insulin (INS) in endocrine cell stage (EC) from control and KO
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hESCs for the indicated lncRNAs (representative images, n ≥ 3 independent differentiations from at least two KO clones). (H) qRT-PCR
analysis of INS in EC stage cultures from control and lncRNA KO (-/-) hESCs. Data are shown as mean ± S.E.M. (n ≥ 4 replicates
from independent differentiations of at least two KO clones). NS, p-value > 0.05; t-test. (I) Flow cytometry analysis at EC stage for INS
in control and KO (-/-) cells for indicated lncRNAs. The line demarks isotype control. Percentage of cells expressing insulin is indicated
(representative experiment, n ≥ 3 independent differentiations each from at least two KO clones). Scale bars = 100 µm. See also Figure
S3 and Table S3
Thus, nine out of ten endoderm- and pancreatic
progenitor-enriched lncRNAs functionally investigated here
appear to be nonessential for induction of the pancreatic fate
and formation of insulin+ cells. Furthermore, these lncRNAs
do not control the transcription of their proximal TFs.
LINC00261 knockout impairs endocrine cell
development
The exception is the endoderm-specific lncRNA LINC00261,
which is highly expressed and translated in pancreatic
progenitors (Figure S4A and Figure 2C). While deletion of
LINC00261 caused no discernable phenotype in definitive
endoderm (Figure 3C-F andFigure S3C), we observed
a significant 30-50% reduction in the number of insulin+
cells at the endocrine cell stage (Figure 4A,B). This
reduction in insulin+ cell numbers was consistent across
four independently derived LINC00261 KO hESC lines. In
agreement with the reduced insulin+ cell numbers, insulin
content and insulin mRNA levels were also reduced in
LINC00261 KO endocrine stage cultures (Figure 4C,D).
Analysis of insulin fluorescence intensities by flow cytometry
further showed no reduction in insulin levels per cell in one
LINC00261 KO clone and a mild reduction in the three
other clones (Figure 4E), demonstrating that LINC00261
predominately regulates endocrine cell differentiation rather
than maintenance of insulin production in beta cells.
To determine the molecular effects of LINC00261 deletion,
we performed RNA-seq in pancreatic progenitors derived
from LINC00261 KO and control hESCs. Among the
down-regulated genes were the TFs MAFB and PAX4
(Figure 4F, Figure S4B, Table S4A), which are important
regulators of beta cell differentiation (Sosa-Pineda et al.,
1997; Artner et al., 2007). Similar to the absence of
cis-regulatory functions observed in the other lncRNA
KOs, we found no evidence for cis-regulation of FOXA2 by
LINC00261 (Figure 4F and Figure S4C). Of note, the genes
differentially expressed in LINC00261 KO cells mapped to all
chromosomes and showed no enrichment for chromosome
20 where LINC00261 resides (Figure 4G). Combined, our
results suggest a trans- rather than cis-regulatory function
for LINC00261, consistent with its predominantly cytosolic
localization, active translation, and diffuse distribution within
the nucleus (Figure 2C and Figure S4D). This potential
trans functionality prompted us to further investigate
whether LINC00261’s coding or noncoding features are
essential for endocrine cell differentiation.
The LINC00261 transcript, and not the encoded
microproteins, is required for endocrine cell
differentiation
We established that LINC00261 harbors multiple
distinct and highly translated sORFs, which produce
poorly conserved microproteins with diverse subcellular
localizations (Figure 2C,F, Figure S2I,K,L, Table S2D).
This raises the possibility that LINC00261-sORF-encoded
microproteins, and not the RNA itself, are functionally
important for endocrine cell differentiation. To systematically
dissect whether the microproteins are required for endocrine
cell formation independent of LINC00261 RNA, we
individually mutated all seven sORFs in independent hESC
lines, leaving the lncRNA sequence grossly intact. Each of
these hESC lines either carries a homozygous frameshift
mutation near the microprotein’s N-terminus (for sORFs
1-6) or a full sORF deletion (sORF7; Table S4B). After
verifying that CRISPR editing of the LINC00261 locus did
not impact LINC00261 transcript levels (Figure S4E), we
quantified (i) insulin mRNA levels, (ii) insulin+ cells, and (iii)
total insulin content in endocrine cell stage cultures. We
observed no difference between sORF loss-of-function and
control hESC lines for any of these endpoints (Figure 4H,I
and Figure S4E). Consistently, transcriptome analysis of
pancreatic progenitors with frameshifts in sORF3 (the most
highly translated LINC00261-sORF; Figure 2C and Table
S2D) revealed no differentially expressed genes between
LINC00261-sORF3 frameshift and control cells (Figure 4J
and Table S4C), contrasting observations in LINC00261
RNA KO pancreatic progenitors (Figure 4F and Table S4A).
It has been suggested that ribosome association can
degrade lncRNAs, e.g. through nonsense-mediated decay
(Tani et al., 2013; Carlevaro-Fita et al., 2016). Therefore,
to determine whether the multiple sORFs within LINC00261
regulate LINC00261 stability, we simultaneously mutated
start codons of all seven sORFs (∆ATGsORF1-7 LINC00261)
and expressed either wild type or ∆ATGsORF1-7 LINC00261
ectopically in HEK293T cells where LINC00261 is normally
not expressed. LINC00261 half-life measurements upon
transcriptional inhibition with actinomycin D revealed no
difference in LINC00261 levels between wild type and
∆ATGsORF1-7 LINC00261 (Figure 4K), suggesting that the
association of LINC00261 with ribosomes does not affect its
stability.
In sum, through the systematic, one-by-one removal of
microproteins produced from a highly translated lncRNA
with functional importance for pancreatic endocrine
cell formation, we found no evidence to implicate the
individual microproteins in endocrine cell development.
Although LINC00261’s microproteins may share functional
redundancy or have developmental roles that do not affect
the production of insulin+ cells, our findings strongly suggest
that by themselves, each of the LINC00261-sORF-encoded
microproteins is not functionally required for endocrine cell
formation.
DISCUSSION
The highly translated lncRNA LINC00261 is a novel
regulator of endocrine cell differentiation
In this study, we globally characterized molecular features of
lncRNAs expressed during progression of hESCs toward the
pancreatic lineage, including their subcellular localization
and potential to be translated and to produce microproteins.
We performed a phenotypic CRISPR loss-of-function
screen, focusing on ten developmentally regulated, highly
expressed, and highly translated lncRNAs proximal to TFs
known to regulate pancreas development.
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Figure 4. LINC00261 deletion impedes pancreatic endocrine cell differentiation.
(A) Flow cytometry analysis at endocrine cell stage (EC) for insulin (INS) in control (ctrl) and LINC00261-/- H1 hESCs. Top panel:
Schematic of the LINC00261 locus. The dashed box represents the genomic deletion. Middle panel: The line demarks isotype control.
Percentage of cells expressing INS is indicated (representative experiment, n = 4 deletion clones generated with independent sgRNAs).
Bottom panel: Bar graph showing percentages of INS-positive cells. Data are shown as mean ± S.D. (n = 5 (clone 1), n = 6 (clone
2), n = 8 (clone 3), n = 5 (clone 4) independent differentiations). (B) Immunofluorescence staining for INS in EC stage cultures from
control and LINC000261-/- hESCs (representative images, number of differentiations see A). (C) ELISA for INS in EC stage cultures
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from control and LINC00261-/- hESCs. Data are shown as mean ± S.D. (n = 3 (clone 1), n = 2 (clone 2), n = 14 (clone 3), n = 13
(clone 4) independent differentiations). (D) qRT-PCR analysis of INS in EC stage cultures from control and LINC00261-/- hESCs. Data
are shown as mean ± S.E.M. (n = 8 (clone 1), n = 5 (clone 2), n = 11 (clone 3), n = 3 (clone 4) independent differentiations). (E)
Quantification of median fluorescence intensity after INS staining of control and LINC00261-/- EC stage cultures. Data are shown as
mean ± S.D. (n = 5 (clone 1), n = 6 (clone 2), n = 8 (clone 3), n = 5 (clone 4) independent differentiations). iso, isotype control. (F)
Volcano plot displaying gene expression changes in control versus LINC00261-/- PP2 cells (n = 6 independent differentiations from
all four deletion clones). Differentially expressed genes are shown in red (DESeq2; > 2-fold change (FC), adjusted p-value < 0.01)
and blue (> 2-fold change, adjusted p-value ≥ 0.01 and ≤ 0.05). Thresholds are represented by vertical and horizontal dashed lines.
FOXA2 in cis to LINC00261 is shown in gray (gray dots represent genes with ≤ 2-fold change and/or adjusted p-value > 0.05). (G)
Circos plot visualizing the chromosomal locations of the 108 genes differentially expressed (DESeq2; > 2-fold change (FC), adjusted
p-value < 0.01) in LINC00261-/- compared to control PP2 cells, relative to LINC00261 on chromosome 20. No chromosome was over-
or underrepresented (Fisher test, p-value > 0.05 for all chromosomes). (H) Top panel: Schematic of the LINC00261 locus, with the
location of its sORFs (1 to 7) marked by vertical red bars. Bottom panel: Flow cytometric quantification of INS-positive cells in control and
LINC00261-sORF-frameshift (FS) at the EC stage. Data are shown as mean ± S.D. (n = 4-7 independent differentiations per clone). (I)
ELISA for INS in EC stage cultures from control and LINC00261-sORF-FS hESCs. Data are shown as mean ± S.D. (n = 3-7 independent
differentiations per clone). (J) Volcano plot displaying gene expression changes in control versus LINC00261-sORF3-FS PP2 cells.
No gene was differentially expressed (DESeq2; > 2-fold change, adjusted p-value < 0.01; indicated by dashed horizontal and vertical
lines; n = 2 independent differentiations). LINC00261 is shown in gray, the bar graph insert displays LINC00261 RPKM values in control
and LINC00261-sORF3-FS PP2 cells. (K) LINC00261 half-life measurements in HEK293T cells transduced with lentivirus expressing
either wild type (WT) LINC00261 or ∆ATGsORF1-7 LINC00261 (mutant in which the ATG start codons of sORFs 1-7 were changed to
non-start codons). HEK293T were treated with the transcription inhibitor actinomycin D and RNA isolated at 0, 2, 4, 6, 8, and 9 hours
post actinomycin D addition. LINC00261 expression was analyzed by qRT-PCR relative to the TBP gene. Data are shown as mean ±
S.E.M. (n = 3 biological replicates for each assay time point). *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value <
0.0001; NS, p-value > 0.05; t-test. Scale bars = 100 µm. See also Figure S4 and Table S4.
The first important observation from this screen is that
we find no evidence to implicate the lncRNAs LINC00261,
DIGIT, GATA6-AS1, SOX9-AS1, and RP11-445F12.1 in
the cis-regulation of their neighboring TFs FOXA2, GSC,
GATA6, SOX9, and LHX, respectively, despite tight
transcriptional coregulation of the lncRNA-TF pairs.
Second, we identify the translated lncRNA LINC00261 as
a novel regulator of pancreatic endocrine cell differentiation,
as evidenced by a severe reduction in insulin+ cell numbers
upon LINC00261 deletion. We show that LINC00261
transcripts are highly abundant in pancreatic progenitors
and, albeit present in the nucleus, are predominantly
localized to the cytoplasm. Here, they frequently
associate with ribosomes to produce multiple distinct
microproteins. Through the introduction of individual
frameshift mutations in each of the microprotein-encoding
sORFs of LINC00261, we could uncouple the requirement of
LINC00261 in endocrine cell development from microprotein
production. Furthermore, mutating all translated LINC00261
sORFs simultaneously and thereby significantly reducing
LINC00261’s ability to bind ribosomes, did not affect
LINC00261 transcript levels.
This indicates that, in contrast to some reports suggesting
that translated sORFs can regulate RNA stability by
promoting nonsense-mediated RNA decay (Tani et al., 2013;
Carlevaro-Fita et al., 2016), the high translation levels and
multiple sORFs of LINC00261 are not part of a LINC00261
decay pathway.
Although lncRNAs are now appreciated as a novel
and abundant source of sORF-encoded biologically active
microproteins (Makarewich & Olson, 2017), we found no
essential roles for LINC00261-sORF-encoded microproteins
in endocrine cell development. Possibly, this is explained
by the fact that most microproteins - including the
majority of microproteins newly identified in this study,
and all microproteins produced by LINC00261 - are poorly
conserved across species. Since the functional role of
the vast majority of such recently evolved microproteins
has not been systematically investigated, there is an
ongoing debate about their significance for vital cellular
processes (Ruiz-Orera et al., 2018; Levy, 2019). Recent
reports, however, suggest that lowly conserved sORFs can
indeed have important functions in terminally differentiated
cells and in cancer (van Heesch et al., 2019; Chen
et al., 2020; Prensner et al., 2020). This raises the
possibility that LINC00261-sORF-encoded microproteins
could possess functions that become relevant under specific
environmental, developmental, or disease conditions not
examined in this study.
LINC00261 - a potential trans regulator of endocrine cell
differentiation?
Several lines of evidence suggest that LINC00261
regulates endocrine cell differentiation in trans: (i)
LINC00261 transcripts show a diffuse distribution in multiple
subcellular compartments, (ii) genes differentially expressed
in LINC00261 KO cells are randomly distributed throughout
the genome, (iii) expression of the nearby TF FOXA2
is not affected by LINC00261 deletion. Such a trans
regulatory mechanism for LINC00261 is supported by a
recent study from the GTEx Consortium, where LINC00261
is highlighted as one of a few lncRNAs that forms a potential
trans regulatory hotspot through genetic interactions that
influence the expression of multiple distant genes (Aguet
et al., 2019). Consistent with its preferential cytosolic
localization, and further supporting the notion of a trans
regulatory mechanism, LINC00261 has been suggested to
regulate gene expression through non-nuclear mechanisms,
e.g. by preventing nuclear translocation of β-catenin (Wang
et al., 2017) or by acting as a miRNA sponge (Shi et al.,
2019; Wang et al., 2019; Yan et al., 2019). Although
our observations and current literature strongly hint to a
function in trans independent of the produced microproteins,
the exact mechanism by which LINC00261 regulates
gene expression in pancreatic progenitors remains to be
determined.
We here present a rigorous, in-depth characterization
of dynamically regulated and translated lncRNAs in a
disease-relevant cell context of human developmental
progression. Our combination of ultra-high-coverage
RNA and Ribo-seq, protein-level validation of microprotein
production and localization, and the systematic deletion of
all individual microproteins encoded by a single translated
lncRNA, not only provides a detailed resource of translated
’non-canonical’ sORFs and their microproteins in pancreatic
development, but also serves as a blueprint for the
systematic functional interrogation of translated lncRNAs
during human organ development.
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Materials and Methods
HEK293T cell culture
HEK293T cells (female) were cultured in a humidified incubator at 37 °C with 5% CO2 using Dulbecco’s Modified Eagle
Medium (Cat# 45000-312; 4.5 g/L glucose, [+] L-glutamine, [-] sodium pyruvate) supplemented with 10% fetal bovine
serum (FBS).
hESC culture and maintenance
H1 hESCs (male) were grown in feeder-independent conditions on
Matrigel®-coated dishes (Corning) with mTeSR1 media (STEMCELL Technologies). Propagation was carried out by
passing the cells every 3 to 4 days using AccutaseTM (eBioscience) for enzymatic cell dissociation. hESC research
was approved by the University of California, San Diego, Institutional Review Board and Embryonic Stem Cell Research
Oversight Committee.
Pancreatic differentiation
H1 hESCs were differentiated in a monolayer format as previously described (Rezania et al., 2012), with minor
modifications. Undifferentiated hESCs were seeded into 24-wells at 0.4× 106 cells/well in 500 µl mTeSR1 medium. The
next day the cells were washed in RPMI media (Thermo Fisher Scientific) and then differentiated with daily media changes.
In addition to GlutaMAXTM, RPMI medium was supplemented with 0.12% (w/v) NaHCO3 and 0.2% (Day 0) or 0.5% (Day
1-3) (v/v) FBS (Corning). DMEM/F12 medium (Corning; 45000-350) was supplemented with 2% (v/v) FBS and 0.2%
(w/v) NaHCO3, and DMEM High Glucose medium (HyClone) was supplemented with 0.5X B-27TM supplement (Thermo
Fisher Scientific). Human Activin A, mouse Wnt3a, human KGF, and human Noggin were purchased from R&D Systems.
Other media components included TGFβ R1 kinase inhibitor IV (EMD Bioscience), KAAD-Cyclopamine (Toronto Research
Chemicals), the retinoid analog TTNPB (Sigma Aldrich), the protein kinase C activator TPB (EMD Chemicals), the BMP
type 1 receptor inhibitor LDN-193189 (Stemgent), and an inhibitor of the TGF-β type 1 activin like kinase receptor ALK5,
ALK5 inhibitor II (Enzo Life Sciences).
Stage 1 (DE; collection on day 3):
Day 0: RPMI/FBS, 100 ng/mL Activin A, 25 ng/mL mouse Wnt3a
Day 1 – 2: RPMI/FBS, 100 ng/mL Activin A
Stage 2 (GT; collection on day 6):
Day 3: DMEM/F12/FBS, 2.5 µM TGFβ R1 kinase inhibitor IV, 50 ng/mL KGF
Day 4 – 5: DMEM/F12/FBS, 50 ng/mL KGF
Stage 3 (PP1; collection on day 10):
Day 6 – 9: DMEM/B27, 3nM TTNPB, 0.25 mM KAAD-Cyclopamine, 50 ng/mL Noggin
Stage 4 (PP2; collection on day 13):
Day 10 – 12: DMEM/B27, 100 nM ALK5 inhibitor II, 100 nM LDN-193189, 500 nM TPB, 50 ng/mL Noggin
Stage 5 (endocrine cell stage; collection on day 16):
Day 13 – 15: DMEM/B27, 100 nM ALK5 inhibitor II, 100 nM LDN-193189, 500 nM TPB, 50 ng/mL Noggin
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For ribosome profiling experiments, a scalable suspension culture protocol was employed for differentiation of H1
cells to the PP2 stage (Rezania et al., 2014). Undifferentiated hESCs were aggregated by preparing a single cell
suspension in mTeSR1 media (STEMCELL Technologies; supplemented with 10 µM Y-27632) at 1× 106 cells/mL and
overnight culture in six-well ultra-low attachment plates (Costar) with 5.5 ml per well on an orbital rotator (Innova2000,
New Brunswick Scientific) at 100 rpm. The following day, undifferentiated aggregates were washed in MCDB 131 media
(Thermo Fisher Scientific) and then differentiated using a multistep protocol with daily media changes and continued
orbital rotation at either 100 rpm or at 115 rpm from days 8 to 14. In addition to 1% GlutaMAXTM (Gibco) and 10 mM (days
0-10) or 20 mM (days 11-14) glucose, MCDB 131 media was supplemented with 0.5% (days 0-5) or 2% (days 6-14) fatty
acid-free BSA (Proliant), 1.5 g/L (days 0-5 and days 11-14) or 2.5 g/L (days 6-10) NaHCO3 (Sigma-Aldrich), and 0.25 mM
ascorbic acid (days 3-10).
Human Activin A, mouse Wnt3a, and human KGF were purchased from R&D Systems. Other media
components included Insulin-Transferrin-Selenium-Ethanolamine (ITS-X; Thermo Fisher Scientific; days 6-10), retinoic
acid (RA) (Sigma-Aldrich), the sonic hedgehog pathway inhibitor SANT-1 (Sigma-Aldrich), the protein kinase C activator
TPB (EMD Chemicals), the BMP type 1 receptor inhibitor LDN-193189 (Stemgent), and the TGFβ type 1 activin like kinase
receptor ALK5 inhibitor, ALK5 inhibitor II (Enzo Life Sciences).
Stage 1 (DE; collection on day 3):
Day 0: MCDB 131, 100 ng/mL Activin, 25 ng/mL mouse Wnt3a
Day 1 – 2: MCDB 131, 100 ng/mL Activin A
Stage 2 (GT; collection on day 6):
Day 3 – Day 5: MCDB 131, 50 ng/mL KGF
Stage 3 (PP1; collection on day 8)
Day 6 – Day 7: MCDB 131, 50ng/mL KGF, 0.25 µM SANT-1, 1 µM RA 100 nM LDN-193189, 200 nM TPB
Stage 4 (PP2; collection on day 11):
Day 8 – Day 10: MCDB 131, 2ng/mL KGF, 0.25 µM SANT-1, 0.1 µM RA, 200 nM LDN-193189, 100 nM TPB
CRISPR/Cas9-mediated lncRNA knockout
To generate clonal lncRNA knockout hESC lines, combinations of pSpCas9(BB)-2A-Puro plasmid pairs
(Addgene plasmid # 62988, gift from Feng Zhang) expressing Cas9 and single sgRNAs targeting upstream and
downstream regions of the lncRNA promoter/locus were co-transfected into 1.5× 106 H1 hESCs using the Human Stem
Cell Nucleofector Kit 2 (Lonza) and the Amaxa Nucleofector II (Lonza). 24 hours after plating into Matrigel®-coated six-well
plates, nucleofected cells were selected with puromycin (1 µg/mL mTeSR1 media) for 2-3 consecutive days. Individual
colonies that emerged within 7 days after transfection were subsequently transferred manually into 96-well plates for
expansion. Genomic DNA for PCR genotyping with GoTaq® Green Mastermix (Promega) and Sanger sequencing was
then extracted using QuickExtract™ DNA Extraction Solution (Lucigen). The PDX1 knockout line was generated in an
analogous way.
To generate sORF frameshift mutations, sgRNA sequences targeting the N-terminal region of the predicted small
peptides were inserted into pSpCas9(BB)-2A-GFP (Addgene plasmid #48138, gift from Feng Zhang) via its BpiI cloning
sites. 3 µg of the resulting plasmids were then transfected into 500,000 H1 cells plated into Matrigel®-coated six-wells
the day prior, using XtremeGene 9 Transfection Reagent (Sigma-Aldrich) according to the manufacturer’s instructions. 24
hours post-transfection, 10,000 GFP+ cells were sorted on an Influx™Cell Sorter (BD Biosciences) into Matrigel®-coated
six-wells containing 1 mL mTeSR1 media supplemented with 10 µM ROCK inhibitor and 1X penicillin/streptomycin.
Seven days after sorting, emerging colonies were hand-picked and transferred into 96-well plates for genotyping.
Frame-shifts inside the targeted sORFs were confirmed by PCR-amplification of the sORF sequence with GoTaq® Green
Mastermix and subsequent subcloning the PCR products into pCR2.1 (Thermo Fisher Scientific). For each hESC clone, at
least six pCR2.1 clones were Sanger sequenced. Oligonucleotide sequences for sgRNA cloning are provided in Table S5A.
PCR genotyping of CRISPR clones
Four days after transfer of single cell-derived clones into 96-wells, cell culture supernatants containing dead cells were
collected from each well prior to the daily media change. Cell debris was then pelleted and used for gDNA extraction
with 10-20 µl QuickExtract™DNA Extraction Solution (Lucigen) according to the manufacturer’s instructions. 1 µl DNA
was then PCR-amplified with GoTaq® Green Mastermix (Promega) and locus-specific primers that anneal either within
or outside of the excised genomic DNA. PCR products generated with “inside” primers were visualized on a 2% agarose
gel, PCR bands generated with primers flanking the deletion were gel-purified and submitted for Sanger sequencing (see
Table S5B for genotyping and sequencing primers).
For genotyping of sORF frameshift clones, PCR amplicons designed to encompass the Cas9 cut site were amplified and
Sanger sequenced (Table S5B). If out-of-frame indels were apparent in the sequencing chromatogram, the sequenced
PCR product was ligated into pCR2.1-TOPO via TOPO-TA cloning. A minimum of six clones were Sanger sequenced in
order to determine the genotype at both alleles with high confidence.
Generation of sORF translation reporter plasmids
The four lncRNAs tested were PCR-amplified with KOD Xtreme™DNA Hotstart Polymerase (Millipore) from their 5’ end
up until the last codon of the sORF to be tested, omitting its stop codon (primer sequences are listed in Table S5D). cDNA
was used as PCR template for LINC00261 and LHFPL3-AS2; RP11-834C11.4, and MIR7-3HG were amplified from a
gBlock synthetic gene fragment (Integrated DNA Technologies; see Table S5F). The GFP coding sequence (without start
codon; amplified from pRRLSIN.cPPT.PGK-GFP.WPRE) was then fused in-frame to the sORF via overlap extension PCR.
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The resulting fusion product was cloned into pRRLSIN.cPPT.PGK-GFP.WPRE via BshTI and SalI restriction sites included
in the PCR primers. Due to the 3’-location of sORF7 within LINC00261, not the entire LINC00261 cDNA was amplified but
only 65 bp preceding sORF7.
To create the RP11-834C11.4-sORF-1XFLAG reporter construct in an analogous way, a gBlock synthetic gene fragment
encompassing the FLAG-tagged sORF served as PCR template (Table S5F). The resulting PCR product was cloned into
pRRLSIN.cPPT.PGK-GFP.WPRE via BshTI and SalI restriction sites.
Generation of LINC00261 wild type and ∆ATGsORFS1-7 expression plasmids
The LINC00261 wild type cDNA was PCR-amplified from pENTR/D-TOPO-LINC00261 (gift from Leo Kurian) with KOD
Xtreme™DNA Hotstart Polymerase (Millipore). The resulting PCR product was inserted into pRRLSIN.cPPT.PGK-GFP.WPRE
via its appended BshTI/SalI cloning sites. Full-length LINC00261 ∆ATGsORFS1-7 was assembled through overlap extension
PCR from the following three fragments and subsequently cloned into pRRLSIN.cPPT.PGK-GFP. WPRE via appended
BshTI/SalI cloning sites: (i) a 1,248 bp PCR product amplified from a synthetic gene construct (Genewiz; see Table S5F
for sequence) in which the ATG start codons of sORFs 1-6 had been mutated (ATG AAG / ATT / AGG / AAG / ATA / AGG),
and (ii-iii) 3,111 bp/610 bp PCR fragments (amplified from the LINC00261 cDNA) in which the sORF7 start codon was
mutated (ATG AAG). The obtained plasmids were sequence-verified by Sanger sequencing.
Immunofluorescence staining
H1 hESC-derived cells grown as monolayer on Matrigel®-coated coverslips were washed twice with PBS and then
fixed with 4% paraformaldehyde in PBS for 30 min at room temperature. Following three washes in PBS, samples
on coverslips were permeabilized and blocked with Permeabilization/Blocking Buffer (0.15% (v/v) Triton X-100 and 1%
normal donkey serum in PBS) for 1 hour at room temperature. Primary and secondary antibodies were diluted in
Permeabilization/Blocking Buffer. Sections were incubated overnight at 4°C with primary antibodies, and then secondary
antibodies for 30 min at room temperature. The following primary antibodies were used: rabbit anti-OCT4 (Cell Signaling
Technology, 1:500), goat anti-SOX17 (Santa Cruz Biotechnology, 1:250), goat anti-FOXA2 (Santa Cruz Biotechnology,
1:250), goat anti-GATA6 (Santa Cruz Biotechnology, 1:50), guinea pig anti-insulin (Dako). Secondary antibodies (1:1000)
were Cy3-, Cy5-, Alexafluor488-conjugated antibodies raised in donkey against guinea pig, rabbit, mouse, or goat (Jackson
Immuno Research Laboratories). Images were acquired on a Zeiss Axio-Observer-Z1 microscope with a Zeiss AxioCam
digital camera, and figures prepared with Adobe Photoshop/Illustrator CS5.
Flow cytometry analysis
For intracellular flow cytometry, single cells were washed three times in FACS buffer (0.1% (w/v) BSA in DPBS) and then
fixed and permeabilized with Cytofix/Cytoperm Fixation/Permeabilization Solution (BD Biosciences) for 20 min at 4 °C,
followed by two washes in BD Perm/WashTM Buffer. Cells were next incubated with either PE-conjugated anti-SOX17
antibody (BD Biosciences), or PE-conjugated anti-INS antibody (Cell Signaling Technology) in 50 µl BD Perm/WashTM
Buffer for 60 min at 4 °C. Following three washes in BD Perm/WashTM Buffer, cells were analyzed on a FACSCanto II (BD
Biosciences) cytometer.
Insulin content measurements
To measure total insulin content of endocrine cell stage control and lncRNA KO cells, adherent cultures were enzymatically
detached from a 24-well at day 16 of differentiation. Upon quenching with FACS buffer (0.1% (w/v) BSA in DPBS), the cells
were pelleted and extracted over night at 4 °C in 100 µl acid-ethanol (2% HCl in 80% ethanol). Insulin was measured by
Insulin ELISA (Alpco) and normalized to total protein, as quantified with a BCA protein assay (Thermo Fisher Scientific).
Quantitative reverse transcription PCR (qRT-PCR)
Total RNA was isolated from hESC-derived cells and HEK293T cells using either TRIzol® (Thermo Fisher Scientific) or the
RNAeasy Mini Kit (Qiagen), respectively. Upon removal of genomic DNA (TURBO DNA-freeTM Kit or RNase-free DNase
Set) cDNA was synthesized using the iScriptTM cDNA Synthesis Kit (Bio-Rad). PCR reactions were run in triplicate with
6.25-12.5 ng cDNA per reaction using the CFX96 Real-Time PCR Detection System (BioRad). TATA-binding protein (TBP)
was used as endogenous control to calculate relative gene expression using the ∆∆Ct method. Primer sequences are
provided in Table S5C.
Transient transfection of HEK293T cells with polyethylenimine (PEI)
Two hours prior to transfection, fresh pre-warmed DMEM medium (Corning) was added to each well.
Transfection mix was prepared by combining PEI and plasmid DNA (4:1 ratio; 4 µg PEI per 1 µg DNA) in Opti-MEMTM
Reduced Serum Medium (Thermo Fisher Scientific) followed by brief vortexing. After five minutes, the transfection complex
was added dropwise to the cells.
Lentivirus preparation and ectopic LINC00261 expression
Lentiviral particles were prepared by co-transfecting HEK293T cells (using PEI) with the pCMVR8.74/pMD2.G helper
plasmids and with pRRLSIN.cPPT.PGK-GFP.WPRE transfer plasmid, in which the GFP ORF had been replaced with
the 4.9 kb LINC00261 cDNA. Virus-containing supernatant was collected for two consecutive days and concentrated by
ultracentrifugation for 2 hours at 19,400 rpm using an Optima L-80 XP Ultracentrifuge (Beckman Coulter).
To express LINC00261 (wild type) and LINC00261 (∆ATGsORF1-7) in HEK293T cells, the cells were plated in 6-well
plates and transduced with lentivirus the following day. Two days post infection, the cells were passaged for RNA half-life
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measurements
LINC00261 RNA half-life measurement
HEK293T cells transduced with either LINC00261 (wild type) or LINC00261 (∆ATGsORF1-7) lentivirus were seeded in six
24-wells. 48 hours after plating, cells from one well were collected for RNA isolation as the “0 hour” time point. To the
remaining five wells, 100 µl growth media supplemented with 10 µg/ml actinomycin D were added to inhibit transcription.
At 2, 4, 6, 8, and 9 hours following actinomycin D addition, samples were collected for RNA isolation. Total RNA was
then reverse transcribed and analyzed by qPCR, where the abundance of each time point was calculated relative to the
abundance at the 0 hour time point (∆Ct). The half-life was then determined by non-linear regression (One phase decay;
GraphPad Prism).
Single molecule RNA fluorescence in situ hybridization (smRNA FISH)
H1-derived PP2 stage cells (control and LINC00261 KO) were cultured on Matrigel®-coated 12 mm diameter coverslips in
a 24-well plate. Following 10 min fixation in 1 mL Fixation Buffer (3.7 % (v/v) formaldehyde in 1X PBS) at room temperature,
the cells were washed twice in PBS and subsequently permeabilized in 70 % (v/v) ethanol for one hour at 4 °C. Following
a five minute wash in Stellaris RNA FISH Wash Buffer A (LGC Biosearch Technologies; 1:5 diluted concentrate, with 10%
(v/v) formamide added), the coverslips were incubated in a humidified chamber at 37 °C for 14 hours with probes diluted in
Stellaris RNA FISH Hybridisation Buffer (LGC Biosearch Technologies; with 10% (v/v) formamide added) to 125 nM. After
a 30 min wash at 37 °C in Wash Buffer A, the cells were counter-stained with Hoechst 33342 (Thermo Fisher Scientific)
for 15 min and washed in RNA FISH Wash Buffer B (LGC Biosearch Technologies) for 5 min at room temperature. The
coverslips were mounted in Vectashield Mounting Medium (Vector Laboratories) and imaged on a UltraView Vox Spinning
Disk confocal microscope (PerkinElmer) using a 100X oil objective.
In vitro transcription/translation of lncRNAs
Synthetic gene constructs containing complete transcript isoforms (including the predicted 5’ and 3’ UTR) of four translated
lncRNAs (RP11-834C11.4, LINC00261, MIR7-3HG, and LHFPL3-AS2) were produced by Genewiz (constructs available
upon request). Microproteins were translated in vitro from 0.5 µg linearized plasmid DNA using the TnT® Coupled
Wheat Germ Extract system (Promega) in the presence of 10 mCi/mL [35S]-methionine (Hartmann Analytic) according
to manufacturer’s instructions. 5 µL lysate was denatured for 2 min at 85 °C in 9.6 µL Novex Tricine SDS Sample Buffer
(2X) (Thermo Fisher Scientific) and 1.4 µL DTT (500 mM). Proteins were separated on 16% Tricine gels (Thermo Fisher
Scientific) for 1 h at 50 V followed by 3.5 h at 100 V and blotted on PVDF-membranes (Immobilon-PSQ Membrane, Merck
Millipore). Incorporation of [35S]-methionine into newly synthesized proteins enabled the detection of translation products
by phosphor imaging (exposure time of 1 day).
In vivo translation assays
Reporter plasmids were transfected into HEK293T cells using PEI, and 36 hours post transfection live cells were imaged
on an EVOS Cell Imaging System (Thermo Fisher Scientific) equipped with a 20X objective. Additional constructs were
generated that served as negative controls (no GFP fluorescence):
1) a LINC00261-sORF3-GFP construct with a single ‘T’ insertion inside sORF3, causing a frame-shift,
2) a LINC00261-sORF2-GFP construct with a stop codon preceding the GFP coding sequence, and
3) a LINC00261-sORF1-GFP construct with a frame-shift mutation within the GFP coding sequence.
Stranded mRNA-seq library preparation for lncRNA KOs
Total RNA from PP2 cells differentiated with the Rezania et al. (2012) protocol was isolated and DNase-treated using
either TRIzol® (Thermo Fisher Scientific), or the RNAeasy Mini kit (Qiagen) according to the manufacturer’s instructions.
RNA integrity (RIN >8) was verified on the Agilent 2200 TapeStation (Agilent Technologies), and 400 ng RNA was used for
multiplex library preparation with the KAPA mRNA HyperPrep Kit (Roche). All libraries were evaluated on TapeStation High
Sensitivity DNA ScreenTapes (Agilent Technologies) and with the Qubit dsDNA High Sensitivity (Life Technologies) assays
for size distribution and concentration prior to pooling the multiplexed libraries for single-end 1x51nt or 1x75 sequencing on
the HiSeq 2500 or HiSeq 4000 System (Illumina). Libraries were sequenced to a depth of >20M uniquely aligned reads.
Cell fractionation and ribo-minus RNA-seq
H1 hESCs were differentiated to the PP2 stage with the Rezania et al. (2012) protocol, then nuclear and cytosolic RNA was
isolated with the Paris™ Kit (Thermo Fisher Scientific). Unfractionated total RNA was set aside as a control. All samples
were DNaseI-treated prior to further processing (TURBO DNA-freeTM Kit; Thermo Fisher Scientific). rRNA-depleted total
RNA-seq libraries were prepared with TruSeq® Stranded Total RNA Library Prep Gold (Illumina), and sequencing was
performed on a HiSeq4000 instrument.
Alignment of lncRNA KO mRNA-seq samples and processing for gene expression analysis
Using the Spliced Transcripts Alignment to a Reference (STAR) aligner (STAR 2.5.3b; (Dobin et al., 2013)), sequence
reads were mapped to the human genome (hg38/GRCh38) with the Ensembl 87 annotations in 2-pass mapping mode,
allowing for up to 6 mismatches. Cufflinks (part of the Cufflinks version 2.2.1 suite (Trapnell et al., 2010; Roberts et al.,
2011)), was then used to quantify the abundance of each transcript cataloged in the Ensembl 87 annotations in reads per
kilobase per million mapped reads (RPKM). For plotting expression values, a pseudocount of 1 was added to all RPKM
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values prior to log2-transformation.
Genes with RPKM ≥ 1 across two replicates were deemed expressed. Differential gene expression was tested
using the DESeq2 v1.10.1 Bioconductor package (Love et al., 2014) with default parameters. Input count files
for DESeq2 were created with htseq-count from the HTSeq Python library (Anders et al., 2015). Genes with a
>2-fold change and an adjusted p-value of <0.01 were considered differentially expressed. The chromosomal
localization of genes differentially expressed upon LINC00261 KO was visualized with the RCircos package in R
(https://cran.r-project.org/web/packages/RCircos/index.html).
LncRNA classifications
The following transcript biotypes were grouped into the “lncRNA” classification: 3’ overlapping ncrna, antisense,
bidirectional promoter lncRNA, lincRNA, macro lncRNA, non coding, processed transcript, sense intronic, sense
overlapping, TEC.
LncRNAs with ≥1 RPKM during all differentiation stages of CyT49 hESCs (ES, DE, FG, GT, PP1, PP2) were categorized
as constitutively expressed (“constitutive”), whereas lncRNAs with <1 RPKM throughout differentiation were considered
“never expressed”. LncRNAs expressed in at least one of the stages (but not in all five stages) were referred to as
dynamically expressed (“dynamic”). Furtheremore, for each lncRNA, its maximum RPKM value was determined across
38 tissues/cell types (see “Gene-gene correlations and GO enrichment” section below). Log2-transformed maximum
expression values (RPKM + pseudocount of 1) were graphed as boxplots for different gene sets using the ggplot2 R
package (https://cran.r-project.org/web/packages/ggplot2/index.html). To determine the subcellular localization
of lncRNAs, first all lncRNAs expressed in the nuclear and/or cytosolic RNA fraction (RPKM ≥ 1 in two biological
replicates) of H1-derived PP2 stage cells were selected. Among these expressed lncRNAs, those with ≥1 RPKMcytosol and
<1 RPKMnucleus were classified as “cytosol enriched”. Conversely, lncRNAs with <1 RPKMcytosol and ≥1 RPKMnucleus were
termed “nucleus enriched”. LncRNAs expressed in both fractions (≥1 RPKMcytosol and ≥1 RPKMnucleus) were tagged with
“both”.
Assignment of lncRNAs to their nearest coding gene using GREAT
GREAT (Genomic Regions Enrichment of Annotations Tool 3.0.0; (McLean et al., 2010)) was run with the “Single nearest
gene” within 1000 kb option to assign the nearest coding genes to the following sets of lncRNAs: i) DE-transcribed
lncRNAs, ii) PP2-transcribed lncRNAs that are not transcribed at the DE stage (non-transcribed control set for i)), iii)
PP2-transcribed lncRNAs, and iv) lncRNAs transcribed at the DE stage but not transcribed in PP2 cells (non-transcribed
control set for iii)). The log2-transformed RPKM values of the lncRNA-associated coding genes were then graphed as
boxplots using ggplot2. The corresponding absolute coding-to-lncRNA inter-gene distances were visualized as cumulative
frequency plots.
Gene-gene correlations and GO enrichment
Pearson correlations were calculated among all genes across a catalog of 38 tissues/cell types derived from all three germ
layers (16 Illumina BodyMap 2.0 tissues, other publicly available data sets (see "Data Sources" below), and EndoC-βH1
RNA-seq data generated in our lab). Scatter plots of the log2-transformed RPKM values for lncRNAs/neighboring TFs and
histograms of the Pearson correlation coefficients were plotted in R using ggplot2.
Spearman correlations were calculated to test for expression coregulation among all genes expressed (RPKM ≥1) in
a minimum of ten out of 38 tissues. The resulting correlation matrix was then used to calculate the Euclidean distance
followed by hierarchical clustering. The resulting heatmap was subdivided into ten clusters. Cluster visualization was
done using heatmap.3 (https://raw.githubusercontent.com/obigriffith/biostar-tutorials/master/Heatmaps/
heatmap.3.R) from gplots v3.0.1 (http://cran.r-project.org/web/packages/gplots/index.html). GO enrichment
(Ashburner et al., 2000; The Gene Ontology, 2019) and KEGG pathway (Kanehisa et al., 2017) analyses to assign
functional annotation to all ten clusters were performed with gProfiler v0.6.4 (Reimand et al., 2016) using g:Profiler archive
revision 1741 (Ensembl 90, Ensembl Genomes 38).
Alignment and processing of ChIP-seq samples
All sequence reads were filtered to include only those passing the standard Illumina quality filter, and then aligned to the
Homo sapiens reference genome (hg38/GRCh38) using Bowtie version 1.1.1 (Langmead et al., 2009). The following
parameters were used to select only uniquely aligning reads with a maximum of two mismatches:
-k 1 –m 1 –l 50 –n 2 –best –strata
SAMtools (Li et al., 2009) was then used to filter reads with a MAPQ score less than 30 and to remove duplicate
reads. Finally, replicate ChIP-seq and input BAM files were merged and sorted. The HOMER makeUCSCfile function
(Heinz et al., 2010) was used to create a bedGraph formatted file for viewing in the UCSC Genome Browser.
Ribosome profiling and matching RNA-seq
Ribosome profiling was performed on PP2 cells obtained from six independent differentiations of H1 hESCs with the
Rezania et al. (2014) protocol, yielding an average of 89% PDX1-positive cells. Ribosome footprinting and sequencing
library preparation was done with the TruSeq® Ribo Profile (Mammalian) Library Prep Kit (Illumina) according to the
TruSeq® Ribo Profile (Mammalian) Reference Guide (version August 2016). In short, 50 mg of PP2 aggregates were
washed twice with cold PBS and lysed for 10 minutes on ice in 1mL lysis buffer (1 x TruSeq Ribo Profile mammalian
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polysome buffer, 1 % Triton X-100, 0.1% NP-40, 1 mM dithiothreitol, 10 U ml-1 DNase I, cycloheximide (0.1 mg/ml) and
nuclease-free H2O). Per sample, 400 µL of lysate was further processed according to manufacturer’s instructions. Final
library size distributions were checked on the Bioanalyzer 2100 using a High Sensitivity DNA assay (Agilent Technologies),
multiplexed and sequenced on an Illumina HiSeq 4000 producing single end 1x51 nt reads. Ribo-seq libraries were
sequenced to an average depth of 85M reads.
Total RNA was isolated using TRIzol® Reagent (Thermo Fisher Scientific) from the exact same cell cultures processed
for ribosome profiling (10% of the total number of cells). Total RNA was DNase treated and purified using the RNA Clean
& ConcentratorTM-25 kit (Zymo Research). RIN scores (RIN = 10 for all 6 samples) were measured on a BioAnalyzer 2100
using the RNA 6000 Nano assay (Agilent Technologies). Poly(A)-purified mRNA-seq library preparation was performed
according to the TruSeq Stranded mRNA Reference Guide (Illumina), using 500 ng of total RNA as input. Libraries were
multiplexed and sequenced on an Illumina HiSeq 4000 producing paired-end 2x101nt reads.
Alignment of Ribo-seq and matched mRNA-seq samples
Prior to mapping, ribosome-profiling reads were clipped for residual adapter sequences and filtered for
mitochondrial, ribosomal RNA and tRNA sequences (Table S2). Next, all mRNA and ribosome profiling data were mapped
to the Ensembl 87 transcriptome annotation of the human genome hg38 assembly using STAR 2.5.2b (Dobin et al., 2013)
in 2-pass mapping mode. To avoid mRNA-seq mapping biases due to read length, 2x101 nt mRNA-seq reads were next
trimmed to 29-mers, those mRNA reads were processed and mapped with the exact same settings as the ribosome
profiling data. For the mapping of 2x101 nt RNA-seq reads 6 mismatches per read were allowed (default is 10), whereas
2 mismatches were permitted for the Ribo-seq and trimmed mRNA-seq reads. To account for variable ribosome footprint
lengths, the search start point of the read was defined using the option –seedSearchStartLmaxOverLread, which was set
to 0.5 (half the read, independent of ribosome footprint length). Furthermore, --outFilterMultimapNmax was set to 20 and
–outSAMmultNmax to 1, which prevents the reporting of multimapping reads.
Detecting actively translated reading frames
Canonical ORF detection using ribosome profiling data was performed with RiboTaper v1.3 (Calviello et al., 2016) with
standard settings. For each sample, we selected only the ribosome footprint lengths for which at least 70% of the reads
matched the primary ORF in a meta-gene analysis. Following the standard configuration of RiboTaper, we required ORFs
to have a minimum length of 8aa, evidence from uniquely mapping reads and at least 21 P-sites. The final list of translation
events was stringently filtered requiring the translated gene to have an average RNA RPKM ≥ 1 and to be detected as
translated in all 6 profiled samples. Furthermore, we required the exact ORF to be detected independently in at least 4 out
of 6 samples.
Translational efficiency estimates
Translational efficiency (TE) estimations were calculated as the ratio of Ribo-seq over mRNA-seq DESeq2 normalized
counts, yielding independent gene-specific TEs for each of the 6 individual replicate differentiations. For this, mRNA-seq
and Ribo-seq based expression quantification was calculated for (annotated and newly detected) coding sequences
(CDSs / ORFs) only, using RNA reads trimmed to footprint sizes as described above.
Data sources
The following datasets used in this study were downloaded from the GEO and ArrayExpress repositories:
RNA-seq: Illumina BodyMap 2.0 expression data from 16 human tissues (GSE30611); polyA mRNA RNA-seq from BE2C
(GSE93448), GM12878 (GSE33480), 293T (GSE34995), HeLa (GSE33480), HepG2 (GSE90322), HUVEC (GSE33480),
Jurkat (GSE93435), K562 (GSE33480), MiaPaCa-2 (GSE43770), Panc1 (GSE93450), PFSK-1 (GSE93451), U-87 MG
(GSE90176); CyT49 hESC/DE/GT/PP1/PP2/CD142+ progenitors/CD200+ polyhormonal cells/in vivo matured endocrine
cells/pancreatic islets (E-MTAB-1086). ChIP-seq: H3K4me3/H3K27me3 in CyT49 hESC/DE/GT/PP1/PP2 (E-MTAB-1086).
Statistical analyses
Statistical analyses were performed using Microsoft Excel, GraphPad Prism (7.05), and R (v.3.5.0). Statistical parameters
such as the value of n, mean, standard deviation (S.D.), standard error of the mean (S.E.M.), significance level (*p < 0.05,
**p < 0.01, ***p < 0.001 and ****p < 0.0001), and the statistical tests used are reported in the figures and figure legends.
The “n” refers to the number of independent pancreatic differentiation experiments analyzed (biological replicates), or the
number of genes/transcripts and sORFs detected. Statistically significant gene expression changes were determined with
DESeq2.
Data availability
All mRNA-seq and Ribo-seq datasets generated for this study have been deposited at GEO under the accession number
GSE144682.
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Supplemental Information
Title: A functional screen of translated pancreatic lncRNAs identifies a microprotein-independent role
for LINC00261 in endocrine cell differentiation
Inventory:
I. Supplemental Data
Figure S1, Related to Figure 1
Figure S2, Related to Figure 2
Figure S3, Related to Figure 3
Figure S4, Related to Figure 4
Table S1 - Related to Figure 1. Identification, regulation, and characterization of lncRNAs during
pancreatic differentiation. (A) Gene expression during pancreatic differentiation (RPKM). (B) lncRNA-proximal TFs,
by cluster in correlation heatmap (Figure S1H). (C) GO enrichment and KEGG pathway analysis for each cluster in the
correlation heatmap (Figure S1D).
(supplied as Excel file: Table S1.xlsx)
Table S2 - Related to Figure 2. RNA-seq after subcellular fractionation and Ribo-seq in PP2
cells. (A) Subcellular fractionation of PP2 stage cells (RPKM). (B) Ribo-seq/mRNA-seq contaminant filtering statistics,
read size distribution, and Pearson correlation coefficients of all sequenced Ribo-seq and polyA RNA-seq libraries. (C)
All ORFs detected by RiboTaper, including lncRNA sORFs. (D) lncRNA sORFs detected by RiboTaper and conservation
statistics (PhyloCSF scores). (E) Translation efficiency calculations.
(supplied as Excel file: Table S2.xlsx)
Table S3 - Related to Figure 3. Differentially expressed genes after lncRNA deletion. (A) Coordinates
of CRISPR deletions. (B) Differentially expressed genes in RP11-445F12.1 knockout at definitive endoderm stage. (C)
Differentially expressed genes in GATA6-AS1 knockout at definitive endoderm stage. (D) Differentially expressed genes
in LINC00261 knockout at definitive endoderm stage. (E) Differentially 75 expressed genes in LINC00617 knockout at
PP2 stage. (F) Differentially expressed genes in GATA6-AS1 knockout at PP2 stage. (G) Differentially expressed genes
in LINC00479 knockout at PP2 stage. (H) Differentially expressed genes in RP11-834C11.4 knockout at PP2 stage. (I)
Differentially expressed genes in SOX9-AS1 knockout at PP2 stage. (J) Differentially expressed genes in MIR7-3HG
knockout at PP2 stage. (K) Differentially expressed genes in LHFPL3-AS2 knockout at PP2 stage.
(supplied as Excel file: Table S3.xlsx)
Table S4 - Related to Figure 4. Characterization of LINC00261 knockout and LINC00261-sORF3-frameshift
PP2 cells. (A) Differentially expressed genes in LINC00261 knockout PP2 stage cells. (B) Sequences of LINC00261
wild type and frameshift mutants. (C) Differentially expressed genes in LINC00261-sORF3-frameshift PP2 stage cells.
(supplied as Excel file: Table S4.xlsx)
Table S5 List of oligonucleotides and synthetic gene fragments used in this study. (A) sgRNA
oligonucleotides used for cloning into PX458/Px459. (B) Genotyping and sequencing primers for KO validation. (C)
qRT-PCR primers. (D) Cloning primers (translation reporter constructs and lentiviral LINC00261 overexpression plasmids).
(E) Synthetic gene fragments. (F) Custom LINC00261 Stellaris® RNA FISH probe set.
(supplied as Excel file: Table S5.xlsx)
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Figure S1. Related to Figure 1. Characterization of lncRNAs expressed during pancreatic differentiation. (A,B)
Left: Expression of the single nearest coding genes (± 1000 kb) in cis to transcribed and non-transcribed lncRNAs at the
DE stage (A) or PP2 stage (B). Log2 transformed mean expression values (RPKM + pseudocount) from two biological
replicates were used to generate the box plots (****, p-value < 0.0001, Wilcoxon rank sum test). Right: Corresponding
cumulative distance distribution functions. (C) Heatmap of the hierarchically clustered expression correlations (Spearman’s
rho) of all RNAs transcribed during pancreatic differentiation (with RPKM ≥ 1 in at least ten out of 38 tissues). Transcription
factor (TF)-encoding mRNAs, lncRNAs (all), dynamically expressed lncRNAs (RPKM ≤ 1 in at least one stage (ESC to
PP2)), and TF-proximal lncRNAs are highlighted above the heatmap. Clusters 8 and 10 are significantly enriched for all
of these RNAs (*, p-value < 0.03, Fisher test). (D) Gene ontology and KEGG pathway analysis for all coding genes in
cluster 8 (p-value < 0.05, Fisher test). The full list of significantly enriched terms is shown in Table S1C. (E-H) H3K4me3
and H3K27me3 ChIP-seq tracks of loci containing lncRNAs GATA6-AS1 (A), LINC00261 (B), PDX1-AS1/PLUTO (C), or
SOX9-AS1 (D) during pancreatic differentiation of CyT49 hESCs.
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Figure S2. Related to Figure 2. Cytosolic lncRNAs engage with ribosomes. (A) Venn diagrams showing the number
of coding RNAs (left) and lncRNAs (right) with RPKM ≥ 1 across two biological replicates in cytosolic and nuclear
factions. (B) Box plots of maximum lncRNA expression (RPKM + pseudocount) across 38 tissues binned by their degree
of cytosolic localization (measured as nuclear/cytosolic lncRNA expression ratio deciles in PP2); the expression of all
PP2-transcribed coding RNAs with dynamic expression during differentiation is included for reference. The pie chart
summarizes the proportions of translated lncRNAs within each cytoplasmic localization decile. (C) Read length distribution
(nt) of Ribo-seq fragments across replicate Ribo-seq experiments (n = 6 biological replicates). (D) Position of the inferred
P-sites of the ribosome footprints relative to the reading frame of PP2-transcribed coding genes. (E-F) Coverage of
29 nt footprint P-sites around the start codons (E) or stop codons (F) of PP2-transcribed coding genes. (G) Box plots
comparing maximum expression of translated and untranslated lncRNAs (RPKM + pseudocount) across 38 tissues (****,
p-value = 2.122x10-8, Wilcoxon rank sum test). For the untranslated set, 285 untranslated PP2-expressed lncRNAs were
selected randomly. (H) Density plots comparing the translation efficiencies of PP2-expressed mRNAs and lncRNAs. (I)
Autoradiograph of radiolabeled in vitro translation products derived from full-length LHFPL3-AS2, MIR7-3HG, LINC00261,
and RP11-834C11.4. EV, empty vector. (J) Anti-FLAG immunofluorescence staining of HEK293T cells transiently
transfected with a PGK-RP11-834C11.4-sORF-1xFLAG construct. (K) Microphotograph of HEK293T cells transiently
transfected with a PGK-LINC00261-sORF4-GFP construct with mitochondria labeled by MitoSOX Red. (L) Golgi
immunofluorescence staining (anti-GM130) of HEK293T cells transiently transfected with a PGK-LINC00261-sORF7-GFP
construct. Scale bars = 10 µm.
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Figure S3. Related to Figure 3. Minor gene expression changes in definitive endoderm or pancreatic progenitor
cells after lncRNA deletion. (A) Genome Browser snap shots of RNA-seq signal at the indicated lncRNA loci in control
(ctrl) and lncRNA knockout (KO; -/-) DE (green tracks) and PP2 (red tracks) stage cells. Genomic deletions are indicated
by gray boxes. (B) Bar graphs showing expression of indicated lncRNAs in control and lncRNA KO DE (green) and PP2
(red) cells quantified by RNA-seq. Data are shown as mean RPKM ± S.D. (n = 2 independent differentiations of two
independent KO clones, except for SOX9-AS1 for which one clone was differentiated twice). (C) Volcano plots displaying
gene expression changes in control versus lncRNA KO DE (green) or PP2 (red) cells. Differentially expressed genes
(DESeq2; > 2-fold change (FC), adjusted p-value < 0.01; vertical and horizontal dashed lines indicate the thresholds; n =
2 independent differentiations of two independent KO clones, except for SOX9-AS1 for which one clone was differentiated
twice) are shown in green (DE) and red (PP2). TF genes in cis to deleted lncRNAs are shown in gray (gray dots represent
genes with ≤ 2-fold change and/or adjusted p-value ≥ 0.01).
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Figure S4. Related to Figure 4. Characterization of LINC00261-deleted pancreatic progenitor cells (A) RNA-seq
expression heatmap of LINC00261 across 35 cell types/tissues originating from all three germ layers (shown as RPKM
+ pseudocount). (B) Heatmap showing K-means clustering of 108 differentially expressed genes (DESeq2; > 2-fold
change (FC), adjusted p-value < 0.01) between PP2 cells from control (ctrl) and LINC00261-/- H1 hESCs (based on
expression z-score; n = 6 independent differentiations). (C) Top: Genome Browser snap shot of RNA-seq signal at the
LINC00261/FOXA2 locus in control and LINC00261-/- PP2 stage cells. Genomic deletions are indicated by gray boxes.
Bottom: Bar graphs showing LINC00261 and FOXA2 expression in control and LINC00261-/- PP2 cells quantified by
RNA-seq. Data are shown as mean RPKM ± S.D. (n = 6 independent differentiations of four independent KO clones). ****,
p-value < 0.0001; NS, p-value > 0.05; t-test. (D) LINC00261 smRNA FISH in control and LINC00261-/- PP2 cells. Scale
bars = 8 µm. (E) qRT-PCR analysis of LINC00261 (top) and INS (bottom) expression in control and LINC00261-sORF-FS
H1 hESC clones at the endocrine cell (EC) stage. Data are shown as mean ± S.E.M. (n ≥ 3 independent differentiations
for each clone).
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